Fact Source: Financial Supervisory Service DART / KOSCOM
💡 3-Second Summary
This filing discloses that Hanwha Ocean’s U.S. subsidiary, Hanwha Ocean USA International LLC, decided to execute a shareholder-allocated rights offering (without issuing new shares) of approximately KRW 363.3B (USD 265M) to secure operating funds and capital for acquiring securities of another corporation.
📊 [Key Disclosure Highlights & Summary]
- Filing Type: Decision on Paid-in Capital Increase (Major Matters of Subsidiary)
- Subsidiary Name: Hanwha Ocean USA International LLC (U.S. Subsidiary / Representative: Seok-Won Lee / Core Business: Maritime Service)
- Decision Date: June 13, 2024 (Board approval date of the subsidiary)
[Detailed Terms of Capital Increase]
- Capital Increase Method: Shareholder-allocated rights offering (No new shares issued)
- Purpose & Allocation of Funds: Total KRW 363,300,000,000 (USD 265,000,000; applied exchange rate of USD 1 = KRW 1,371.00 as of June 14, 2024; rounded to the nearest hundred million KRW)
- Operating Funds: KRW 2,900,000,000 (KRW 2.9B)
- Acquisition of Securities of Other Corporations: KRW 360,400,000,000 (KRW 360.4B)
- Payment Date: December 31, 2024 (Target completion date; capital will be injected in installments based on project progress)
- Treatment of Unsubscribed Shares: Not applicable
[Other Material Notes]
- Specific share details (number of shares, par value, issue price) are omitted as no new shares are issued in this capital increase.
- Exemption from registration statement filing as the subsidiary is an unlisted foreign entity.
- The KRW conversion value may fluctuate depending on exchange rates at the time of actual capital injections.
- Subsidiary asset total (KRW 0) reflects the March 31, 2024 settlement date; a USD 17.2M contribution was completed on April 19, 2024.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Installment Payments and Final Completion Status
This filing details a rights offering by a U.S. subsidiary to raise operating funds and capital for acquiring securities of another corporation, making it essential to monitor whether capital injections are completed in installments as planned by the target payment date (December 31, 2024) in line with project progress. Verifying these developments is necessary because it serves as the benchmark to confirm the execution status of the subsidiary’s financing and capital injection plan. Detailed payment updates can be confirmed through future regular financial reports (Quarterly, Semi-Annual, or Annual Business Reports) or subsequent official public disclosures.
📢 Disclaimer & Source Notice
Source: This content was newly structured based on official data submitted to the Financial Supervisory Service’s DART system and KOSCOM.
Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
